RemeGen Co., Ltd. 榮昌生物製藥(煙台)股份有限公司

Pay for financial year ended 2020-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Supervisors

1 Li, Yupeng (1983) 李宇鵬 Supervisor
2 Li, Zhuanglin 李壯林 Supervisor 760 205 526 1,491
3 Ren, Guangke 任廣科 Sup Ch 313 205 1,297 1,815
Total 0 1,073 410 0 1,823 3,306

Directors

4 Babiuk, Lorne Alan INED 192 192
5 Fang, Jianmin (1962) 房健民 CEO, Co-Fdr 4,636 960 3 5,599
6 Hao, Xianjing 郝先經 INED 192 192
7 He, Ruyi (1961) 何如意 ED 4,152 960 3 4,648 9,763
8 Lin, Jian (1955) 林健 ED 486 403 889
9 Su, Xiaodi 蘇曉迪 NED
10 Wang, Liqiang (1970) 王荔強 NED
11 Wang, Weidong (1959) 王威東 Ch 840 660 1,500
12 Yu, Shanshan (SFC:AZU832) 于珊珊 INED 192 192
Total 576 10,114 2,983 6 4,648 18,327
Grand total 576 11,187 3,393 6 6,471 21,633

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,574 12,688 2,775 42 18,157 35,236 Report
2023-12-31 2,317 14,409 3,709 41 35,376 55,852 Report
2022-12-31 2,293 14,414 3,878 77 36,763 57,425 Report
2021-12-31 900 8,914 5,313 72 6,271 21,470 Report
2020-12-31 576 10,114 2,983 6 4,648 18,327 Report
Total 7,660 60,539 18,658 238 101,215 188,310

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top